(Right to Life UK) – A Chinese biotech firm has declared “screening out” babies with Down syndrome is a “cash cow” funding the growth of the whole business. The admission comes from a spokesperson for BGI Group – a Chinese genetics conglomerate whose main business is offering non-invasive prenatal tests, primarily used to diagnose Down syndrome. In a segment from an Aljazeera documentary titled Genesis 2.0, the spokesperson gestures towards a digital map of the world and says: “You can see clearly, especially for Down’s syndrome, we have nearly two million samples all over the world. This part is, what...